Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced or Metastatic Solid Tumors × TAK-981 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hematologic Neoplasms 1 Advanced or Metastatic Solid Tumors 1

Interventions

pembrolizumab 1 fludarabine 1 cobimetinib 1 TAK-981 1 Nivolumab 1 Ipilimumab 1 Injections 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04381650 2025-12-10

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Takeda

Phase 1/2 Completed

161 enrolled 44 charts

Other solid neoplasm

Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡